Free Republic

After five bewildering years of censorship, lies, injuries, and death at the hands of an experimental gene-damaging injection that was forced upon humanity to solve a manipulated global crisis, for now, times appear to be changing. And while that change can't come soon enough, the villains who exploited society to keep the unprecedented mass-injection scam alive must be held accountable. At the top of that list—orchestrating the scheme from behind the scenes—is Dr. Peter Marks, the former high-ranking U.S. government official tasked with overseeing the regulation of products like vaccines and gene therapies to ensure they are safe and effective...

Pharma stocks tumbled today after Peter Marks, M.D., Ph.D., director of the agency within the U.S. Food and Drug Administration (FDA) responsible for authorizing vaccines, resigned under pressure from his new boss, Health and Human Services (HHS) Secretary Robert F. Kennedy Jr. "If Peter Marks does not want to get behind restoring science to its golden standard and promoting radical transparency, then he has no place at FDA under the strong leadership of Secretary Kennedy," an HHS official said in a statement. Shares of Moderna, BioNTech, Novavax and Pfizer declined 11%, 7%, 6% and 2%, respectively, on the news, Fast...

For a third time, Sarepta Therapeutics has convinced a top Food and Drug Administration official to overrule the prevailing view of their staff and approve a drug for Duchenne muscular dystrophy. On Thursday evening, the FDA announced it expanded the approval of Elevidys, Sarepta’s Duchenne gene therapy, to cover nearly all patients, regardless of age or wheelchair status, despite the fact that the drug failed a large, Phase 3 trial last year. That decision, documents concurrently released by the agency show, was made almost exclusively by Peter Marks, the agency’s director of the Center for Biologics Evaluation and Research. He...

Dr. Peter Marks, the agency’s top vaccine official and a key figure in the first Trump administration’s Operation Warp Speed, has been ousted from his post. ​Dr. Peter Marks is an American hematologist-oncologist who has served as the director of the Center for Biologics Evaluation and Research (CBER) at the U.S. Food and Drug Administration (FDA) since 2016. As CBER director, Marks was responsible for reviewing and providing advice during product development, evaluating applications, and making approval decisions based on safety and effectiveness data. He oversaw the FDA’s vaccine programs and played a pivotal part in the rapid development and...

The Food and Drug Administration’s top vaccine official, Dr. Peter Marks, abruptly resigned Friday, saying in a searing letter that Health Secretary Robert F. Kennedy Jr.’s aggressive stance on vaccines was irresponsible and posed a danger to the public... Dr. Marks resigned under pressure, according to a person familiar with the matter who said an official with the Department of Health and Human Services told Dr. Marks on Friday that he could either resign or be fired...

Vaccines don’t have to prevent infection or transmission to be cleared in the United States, the country’s top regulatory agency said in a new document. “It is important to note that FDA’s authorization and licensure standards for vaccines do not require demonstration of the prevention of infection or transmission,” Dr. Peter Marks, a top official at the U.S. Food and Drug Administration (FDA), said in the document. Marks was writing as he rejected nearly all recommendations from a group of experts that advised the FDA to update the labels for the Pfizer and Moderna COVID-19 vaccines. Vaccines are traditionally known...

Two U.S. agencies have been quietly studying neurological problems that have appeared in people who have had COVID-19 vaccines, The Epoch Times has found. The Food and Drug Administration (FDA) and National Institutes of Health (NIH) have been conducting separate research projects into post-vaccination neurological issues, which have manifested with symptoms like facial paralysis and brain fog and have been linked in some cases with the vaccines, according to emails reviewed by The Epoch Times. One attempt to gain understanding of a problem that experts around the world are struggling to understand is being carried out by Dr. Janet Woodcock,...

Marshall: So more COVID vaccines have now been distributed in such a short period of time, to such a generalized population, than any time in our history. And yet there's still substantial concern and a substantial amount of information that people are questioning. And perhaps for those who are reluctant to get the vaccine, concern about safety. So the FDA and CDC have a reporting system where some of these events are reported either by themselves or by their doctors. So, what are we seeing from that reporting system? Marks: Well, I think what we're seeing is robust reporting of...

BREAKING: In a major blow to vaccine efforts, senior FDA leaders stepping down Two of the FDA’s most senior vaccine leaders are exiting from their positions, raising fresh questions about the Biden administration and the way that it’s sidelined the FDA. Marion Gruber, director of the FDA’s Office of Vaccines Research & Review and 32-year veteran of the agency, will leave at the end of October, and OVRR deputy director Phil Krause, who’s been at FDA for more than a decade, will leave in November. The news, first reported by BioCentury, is a massive blow to confidence in the agency’s...

NEW: About 40-50% of CDC, FDA employees are refusing the COVID-19 vaccine according to Fauci, Marks— Breaking911 (@Breaking911) May 14, 2021